The 2022 review explores the use of PCEs by healthy individuals, noting that short-term cognitive benefits are modest and inconsistently supported by evidence. The article raises concerns about potential harms, including cardiovascular risks, neural disruption, and dependency. Due to limited long-term safety data, the authors argue that non-medical use of these substances remains medically and ethically uncertain.